Tag Archives: CTLA

Immune response and stage 4 melanoma

Stage 4 (Stage IV) melanoma is very difficult to treat.  Even though stage I melanoma has an excellent prognosis; response rate for stage 4 melanoma with palliative biotherapies and chemotherapies is only approximately 10%. Clinicians and researchers are working hard to … Continue reading

Posted in Cancer, Melanoma | Tagged , , , | Comments Off on Immune response and stage 4 melanoma